RTP801 is a critical factor in the neurodegeneration process of A53T α-synuclein in a mouse model of Parkinson's disease under chronic restraint stress

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

(2016) Daniel J Klionsky et al.   Autophagy

ER stress and Parkinson's disease: Pathological inputs that converge into the secretory pathway

(2016) Gabriela Mercado et al.   BRAIN RESEARCH

Rab7 induces clearance of α-synuclein aggregates

(2016) Elisabeth Dinter et al.   JOURNAL OF NEUROCHEMISTRY

Ganglioside GQ1b induces dopamine release through the activation of Pyk2

(2016) Zhao Zhang et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease

(2016) Yan Zhou et al.   Molecular Neurodegeneration

Protective effects of Forsythia suspense extract with antioxidant and anti-inflammatory properties in a model of rotenone induced neurotoxicity

(2016) Shuai Zhang et al.   NEUROTOXICOLOGY

Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra

(2016) Yang Heng et al.   TOXICOLOGY LETTERS

Experimental design and analysis and their reporting: new guidance for publication in BJP

(2015) Michael J Curtis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP

(2015) John C McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

MicroRNA-7: A miRNA with expanding roles in development and disease

(2015) Jessica L. Horsham et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

(2015) Christopher Southan et al.   NUCLEIC ACIDS RESEARCH

Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo

(2014) Edward Rockenstein et al.   BRAIN

REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids

(2014) G. Baida et al.   EMBO Molecular Medicine

Chronic restraint stress promotes learning and memory impairment due to enhanced neuronal endoplasmic reticulum stress in the frontal cortex and hippocampus in male mice

(2014) RONG-RONG HUANG et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

REDD1 is essential for stress-induced synaptic loss and depressive behavior

(2014) Kristie T Ota et al.   NATURE MEDICINE

Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo

(2014) Kelly M. Lohr et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

RTP801/REDD1: a stress coping regulator that turns into a troublemaker in neurodegenerative disorders

(2014) Mercè Canal et al.   Frontiers in Cellular Neuroscience

Endoplasmic Reticulum Stress Is Important for the Manifestations of  -Synucleinopathy In Vivo

(2012) E. Colla et al.   JOURNAL OF NEUROSCIENCE

Protective effects of nizofenone administration on the cognitive impairments induced by chronic restraint stress in mice

(2012) Yi Liu et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Micro-RNA30c Negatively Regulates REDD1 Expression in Human Hematopoietic and Osteoblast Cells after Gamma-Irradiation

(2012) Xiang Hong Li et al.   PLoS One

NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets

(2011) Trond Lamark et al.   CELL CYCLE

Crosstalk between Glucocorticoid Receptor and Nutritional Sensor mTOR in Skeletal Muscle

(2011) Noriaki Shimizu et al.   Cell Metabolism

Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour

(2011) A. Djamshidian et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

miR-495 is upregulated by E12/E47 in breast cancer stem cells and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1

(2011) W W Hwang-Verslues et al.   ONCOGENE

Cortisol is higher in parkinsonism and associated with gait deficit

(2010) A. Charlett et al.   ACTA NEUROLOGICA SCANDINAVICA

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Corticosterone exerts immunostimulatory effects on macrophages via endoplasmic reticulum stress

(2010) J.-Y. Zhou et al.   BRITISH JOURNAL OF SURGERY

Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson’s Disease

(2010) Ashley D. Reynolds et al.   JOURNAL OF IMMUNOLOGY

REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A–DDB1 ubiquitin ligase

(2009) Samiksha Katiyar et al.   EMBO REPORTS

miR-221 overexpression contributes to liver tumorigenesis

(2009) P. Pineau et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease

(2008) Lori K. Smith et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities

(2008) Inki Kim et al.   NATURE REVIEWS DRUG DISCOVERY